NCI Inc. (NASDAQ:NCIT) fell 10.9% during trading on Thursday . The company traded as low as $12.31 and last traded at $12.54, with a volume of 94,799 shares trading hands. The stock had previously closed at $14.08.

A number of research firms have commented on NCIT. FBR & Co restated a “hold” rating on shares of NCI in a research report on Thursday, April 28th. Zacks Investment Research raised NCI from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a research note on Saturday, April 30th. Finally, TheStreet raised NCI from a “hold” rating to a “buy” rating in a research note on Wednesday, May 25th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $14.70.

The company has a 50-day moving average of $13.48 and a 200-day moving average of $13.68. The company has a market capitalization of $169.61 million and a PE ratio of 13.22.

NCI (NASDAQ:NCIT) last announced its earnings results on Wednesday, July 27th. The company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. The company had revenue of $81.90 million for the quarter, compared to analyst estimates of $85.10 million. NCI’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.22 EPS. Equities analysts anticipate that NCI Inc. will post $0.96 earnings per share for the current fiscal year.

Several hedge funds and institutional investors have modified their holdings of the company. Bailard Inc. acquired a new position in shares of NCI during the fourth quarter worth $1,040,000. Dimensional Fund Advisors LP raised its position in shares of NCI by 14.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 257,374 shares of the company’s stock worth $3,513,000 after buying an additional 33,381 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of NCI by 209.8% in the fourth quarter. Morgan Stanley now owns 90,526 shares of the company’s stock worth $1,236,000 after buying an additional 61,301 shares in the last quarter.

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.